Biosimilars getting closer to the US mainstream

The US FDA’s advisory committee recommended Remicade, a biosimiliar with is used to treat several autoimmune diseases, such as Crohn’s Disease and rheumatoid arthritis. The independent panel’s vote makes it more likely that the FDA will rule in a similar way.

Read the source article at Business Insider